XML 12 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2020
Aug. 12, 2020
Cover [Abstract]    
Entity Registrant Name Co-Diagnostics, Inc.  
Entity Central Index Key 0001692415  
Document Type 10-Q/A  
Document Period End Date Jun. 30, 2020  
Amendment Flag true  
Amendment Description We are filing this Amendment No. 1 on Form 10Q/A ("Amended Report") to amend our Quarterly Report for the quarter ended June 30, 2020, that was originally filed with the U.S. Securities and Exchange Commission (the "SEC") on August 13, 2020 (the "Original Report"), to restate our condensed consolidated financial statements for the period ended June 30, 2020. Consequently, the previously filed unaudited condensed consolidated financial statements for the period ended June 30, 2020, should no longer be relied upon. In accordance with applicable SEC rules, this Amended Report also includes new certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, as amended, from our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") dated November 3, 2020 10-Q as of the filing date of this Amended Report.  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   28,082,709
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2020